Chinese expert consensus on biomarkers for heart failure
10.3760/cma.j.issn.1009-9158.2020.02.007
- VernacularTitle: 心力衰竭生物标志物中国专家共识
- Collective Name:Evidence Based Medicine Committee Affiliated to China International Exchange and Promotion Association for Medical and Healthcare;Committee Geriatric Medicine Affiliated to Cross-straits Medicine Exchange Association
- Publication Type:Guideline
- Keywords:
Heart failure;
Biomarkers;
Natriuretic peptides;
Atrial natriuretic factor;
Troponin
- From:
Chinese Journal of Laboratory Medicine
2020;43(2):130-141
- CountryChina
- Language:Chinese
-
Abstract:
Themorbidity and mortality of heart failure (HF) are increasing with the rise of life expectancy in recent years, which emphasize the early diagnosis and optimal treatment. Biomarkers for HF play an important role in the prediction, diagnosis, prognosis and treatment guiding of HF. Natriuretic peptide (NP) is the most widely used biomarkers for HF. However, NP is not an ideal biomarker due to low specificity. Recently, more biomarkers were found to be valuable on the basis of NP in the evaluation of HF. This consensus summarized the biomarkers for HF according to latest clinical guidelines, expert statements and clinical trials. It is meant to provide reference in the application ofbiomarkers for HF.
